United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flavour not specified - powder

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flavour not specified - not applicable

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flavour not specified - powder

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - dextromethorphan hydrobromide monohydrate, quantity: 10.5 mg - pastille - excipient ingredients: menthol; acacia; saccharin sodium; white beeswax; betadex; quinoline yellow; sodium cyclamate; light liquid paraffin; maltitol solution; citric acid; flavour - bisolvon dry pastilles are used for the symptomatic treatment of dry, irritant, unproductive coughs and helps soothe the throat.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 0.8 mg/ml - oral liquid - excipient ingredients: maltitol solution; hyetellose; benzoic acid; sucralose; purified water; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - febantel; pyrantel embonate ; praziquantel - tablet - 150, 144, 50 mg/tablet - febantel, combinations - dogs - endoparasiticide

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - febantel; pyrantel embonate ; praziquantel - tablet - 150, 144, 50 mg/tablet - febantel, combinations - dogs - endoparasiticide

Australia - English - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lidocaine, quantity: 50 mg/g - gel - excipient ingredients: macrogol 4000; macrogol 300; saccharin; cetrimide; flavour - topical anaesthetic for the oral mucosa for use in children and adults to assist during dental procedures. desensitises the mucous membranes prior to injections. surface anaesthesia for the extirpation of deciduous teeth. abscess incisions below the mucous membrane. extraction of teeth with advanced periodontitis, allows adjustment and fitting of crowns and bridges. allows juxtagingival scaling.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate, quantity: 114.82 mg/ml (equivalent: amoxicillin, qty 100 mg/ml) - oral liquid, powder for - excipient ingredients: silicon dioxide; sodium citrate; purified talc; aspartame; sodium benzoate; citric acid; guar gum; flavour - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative organism has not been identified. respiratory tract infections (acute and chronic) including acute otitis media (aom): h. influenzae; streptococcus; s. pneumoniae; staphylococcus, nonpenicillinase producing; e. coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic): e. coli (see microbiology), p. mirabilis and strep. faecalis. gonorrhoea: n. gonorrhoeae (nonpenicillinase producing). skin and skin structure infections: staphlococcus, nonpenicillinase producing; streptococcus, e. coli (see microbiology). prophlaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthe

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate, quantity: 28.77 mg/ml (equivalent: amoxicillin, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: silicon dioxide; sodium citrate; purified talc; aspartame; sodium benzoate; citric acid; guar gum; flavour - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative organism has not been identified. respiratory tract infections (acute and chronic) including acute otitis media (aom): h. influenzae; streptococcus; s. pneumoniae; staphylococcus, nonpenicillinase producing; e. coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic): e. coli (see microbiology), p. mirabilis and strep. faecalis. gonorrhoea: n. gonorrhoeae (nonpenicillinase producing). skin and skin structure infections: staphlococcus, nonpenicillinase producing; streptococcus, e. coli (see microbiology). prophlaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthe